Controversy:
cGVHD management: sufficient evidence to standardize or too complex to simplify?
Saturday, October 3, 2026
13:30–15:00
| AGENDA | |
|---|---|
| 13:30–13:40 | Welcome and introduction Prof. Dr. Daniel Wolff (Chair) |
| 13:40–14:20 | Controversy: cGVHD management – sufficient evidence to standardize or too complex to simplify? |
| 13:40–14:00 | Yes: Dr. Guillermo Ortí |
| 14:00–14:20 | No: Dr. Sandra Easdale |
| 14:20–14:40 | A distinct perspective: Unique challenges of cGVHD management in pediatric and adolescent patients Prof. Lawitschka (pediatric cGVHD specialist) |
| 14:40–15:00 | Panel discussion and closing remarks All speakers |
